Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection — Stella

Recruiting

Back to Coronavirus Infection trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Belgium

CHU de Liège, Liège

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Liege

Enrollment target

~20 participants

Started

June 2020

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov